tetano
Editor, Senior Moderator
Eur J Med Res
. 2024 Apr 20;29(1):243.
doi: 10.1186/s40001-024-01840-5. Influence of vaccination on critical COVID-19 patients with acute respiratory failure: a retrospective cohort study
Hsiao-Chin Shen[SUP] 1 2 3 [/SUP], Jhong-Ru Huang[SUP] 1 2 [/SUP], Chuan-Yen Sun[SUP] 1 2 [/SUP], Ying-Ting Liao[SUP] 1 2 [/SUP], Hung-Jui Ko[SUP] 1 [/SUP], Chih-Jung Chang[SUP] 1 [/SUP], Jia-Yih Feng[SUP] 1 2 [/SUP], Yuh-Min Chen[SUP] 1 2 [/SUP], Wei-Chih Chen[SUP] #[/SUP][SUP] 4 5 6 [/SUP], Kuang-Yao Yang[SUP] #[/SUP][SUP] 1 2 7 8 [/SUP]
Affiliations
Background: Despite vaccines' effectiveness in reducing COVID-19 infection rates and disease severity, their impact on critical patients presenting with acute respiratory failure is elusive. The aim of this study was to further investigate the influence of vaccination on mortality rates among severely ill COVID-19 patients experiencing acute respiratory failure.
Methods: This retrospective cohort study was carried out at a tertiary medical center in Taiwan. From April to September 2022, patients who tested positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through reverse transcription polymerase chain reaction (RT-PCR) and subsequently experienced acute respiratory failure were included in the study. Baseline characteristics, including vaccination history, along with information regarding critical illness and clinical outcomes, were gathered and compared between patients who received the vaccine and those who did not.
Results: A total of 215 patients with COVID-19 exhibiting acute respiratory failure, as confirmed via RT‒PCR, were included in the analysis. Of this cohort, sixty-six (30.7%) patients died within 28 days. Neither administration of the vaccine nor achievement of primary series vaccination status had a significantly different effect on 28 day mortality, number of viral shedding events, acute respiratory distress syndrome (ARDS) incidence or other clinical outcomes. Patients who received the booster vaccine and completed the primary series showed a tendency of increased 28 days of ventilator-free status, though this difference was not statistically significant (p = 0.815).
Conclusions: Vaccination status did not significantly influence mortality rates, the occurrence of ARDS, or the viral shedding duration in COVID-19 patients with acute respiratory failure.
Keywords: Acute Respiratory Distress Syndrome; Acute Respiratory Failure; COVID-19 Vaccines; Coronavirus Disease 2019 (COVID-19); Virus Shedding.
. 2024 Apr 20;29(1):243.
doi: 10.1186/s40001-024-01840-5. Influence of vaccination on critical COVID-19 patients with acute respiratory failure: a retrospective cohort study
Hsiao-Chin Shen[SUP] 1 2 3 [/SUP], Jhong-Ru Huang[SUP] 1 2 [/SUP], Chuan-Yen Sun[SUP] 1 2 [/SUP], Ying-Ting Liao[SUP] 1 2 [/SUP], Hung-Jui Ko[SUP] 1 [/SUP], Chih-Jung Chang[SUP] 1 [/SUP], Jia-Yih Feng[SUP] 1 2 [/SUP], Yuh-Min Chen[SUP] 1 2 [/SUP], Wei-Chih Chen[SUP] #[/SUP][SUP] 4 5 6 [/SUP], Kuang-Yao Yang[SUP] #[/SUP][SUP] 1 2 7 8 [/SUP]
Affiliations
- PMID: 38643153
- PMCID: PMC11031850
- DOI: 10.1186/s40001-024-01840-5
Background: Despite vaccines' effectiveness in reducing COVID-19 infection rates and disease severity, their impact on critical patients presenting with acute respiratory failure is elusive. The aim of this study was to further investigate the influence of vaccination on mortality rates among severely ill COVID-19 patients experiencing acute respiratory failure.
Methods: This retrospective cohort study was carried out at a tertiary medical center in Taiwan. From April to September 2022, patients who tested positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through reverse transcription polymerase chain reaction (RT-PCR) and subsequently experienced acute respiratory failure were included in the study. Baseline characteristics, including vaccination history, along with information regarding critical illness and clinical outcomes, were gathered and compared between patients who received the vaccine and those who did not.
Results: A total of 215 patients with COVID-19 exhibiting acute respiratory failure, as confirmed via RT‒PCR, were included in the analysis. Of this cohort, sixty-six (30.7%) patients died within 28 days. Neither administration of the vaccine nor achievement of primary series vaccination status had a significantly different effect on 28 day mortality, number of viral shedding events, acute respiratory distress syndrome (ARDS) incidence or other clinical outcomes. Patients who received the booster vaccine and completed the primary series showed a tendency of increased 28 days of ventilator-free status, though this difference was not statistically significant (p = 0.815).
Conclusions: Vaccination status did not significantly influence mortality rates, the occurrence of ARDS, or the viral shedding duration in COVID-19 patients with acute respiratory failure.
Keywords: Acute Respiratory Distress Syndrome; Acute Respiratory Failure; COVID-19 Vaccines; Coronavirus Disease 2019 (COVID-19); Virus Shedding.